Summit Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Summit Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5.41M	Sell	90,031 -1,311	-1%	-$80.2K	2.45%	12
2015 Q4	$6.39M	Buy	91,342 +2,622	+3%	+$186K	2.59%	9
2015 Q3	$5.89M	Buy	88,720 +5,613	+7%	+$437K	2.88%	10
2015 Q2	$6.51M	Sell	83,107 -89,445	-52%	-$6.96M	2.78%	10
2015 Q1	$13.2M	Buy	172,552 +2,860	+2%	+$210K	5.31%	4
2014 Q4	$11.3M	Buy	169,692 +72,734	+75%	+$4.84M	4.23%	6
2014 Q3	$6.17M	Buy	96,958 +2,943	+3%	+$182K	2.18%	14
2014 Q2	$5.74M	Sell	94,015 -75,125	-44%	-$4.35M	2.06%	18
2014 Q1	$9.58M	Buy	169,140 +40,389	+31%	+$2.29M	3.39%	6
2013 Q4	$6.89M	Buy	+128,751	New	+$6.44M	2.59%	12

Other funds holding PJP

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Capital Management's PJP Position: Q1 2016 in Review

Summit Capital Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 1.4% in Q1 2016, selling an estimated $80.2K and leaving 90,031 shares worth $5.41M. The position accounts for 2.45% of the portfolio, ranked #12.

Summit Capital Management first reported a position in PJP in Q4 2013 and has held it in 10 quarters since. The position peaked at $13.2M in Q1 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

Summit Capital Management held 90,031 shares of Invesco Pharmaceuticals ETF worth $5.41M as of Q1 2016.
Summit Capital Management sold 1,311 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $80.2K.
Invesco Pharmaceuticals ETF made up 2.45% of Summit Capital Management's portfolio in Q1 2016, its #12 holding.
Summit Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2013 and has held it in 10 quarters since.
Summit Capital Management's Invesco Pharmaceuticals ETF position peaked at $13.2M in Q1 2015.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Summit Capital Management's 13F filing for Q1 2016, filed 11 May 2016.